Jean Pierre Droz

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Girre Véronique; Brain Etienne; Le Caer Hervé; Ghesquières Hervé; Peyrat Patrice; Terret Catherine; Droz Jean-Pierre
[Clinical management of the most important cancers in older patients]
Droz Jean-Pierre
[Geriatric oncology. Integrating the elderly in the program]
Terret Catherine; Castel-Kremer Elisabeth; Albrand Gilles; Droz Jean Pierre
Effects of comorbidity on screening and early diagnosis of cancer in elderly people.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jean Pierre Droz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Girre Véronique; Brain Etienne; Le Caer Hervé; Ghesquières Hervé; Peyrat Patrice; Terret Catherine; Droz Jean-Pierre
[Clinical management of the most important cancers in older patients]
La Revue du praticien 2009;59(3):347-58.
2009: Droz Jean-Pierre
[Geriatric oncology. Integrating the elderly in the program]
La Revue du praticien 2009;59(3):325-7.
2009: Terret Catherine; Castel-Kremer Elisabeth; Albrand Gilles; Droz Jean Pierre
Effects of comorbidity on screening and early diagnosis of cancer in elderly people.
The lancet oncology 2009;10(1):80-7.
2008: Ismaili Nabil; Elkarak Fadi; Heudel Pierre Etienne; Flechon Aude; Droz Jean Pierre
Small cell cancer of the bladder: The Leon-Berard cancer centre experience.
Indian journal of urology : IJU : journal of the Urological Society of India 2008;24(4):494-7.
2008: Droz Jean-Pierre; Aapro Matti; Balducci Lodovico
Overcoming challenges associated with chemotherapy treatment in the senior adult population.
Critical reviews in oncology/hematology 2008;68 Suppl 1():S1-8.
2008: Sherman Steven I; Wirth Lori J; Droz Jean-Pierre; Hofmann Michael; Bastholt Lars; Martins Renato G; Licitra Lisa; Eschenberg Michael J; Sun Yu-Nien; Juan Todd; Stepan Daniel E; Schlumberger Martin J;
Motesanib diphosphate in progressive differentiated thyroid cancer.
The New England journal of medicine 2008;359(1):31-42.
2008: Caponigro Francesco; Cartenì Giacomo; Droz Jean Pierre; Milano Amalia; Davis Wayne B; Pollard Patricia
Phase II study of rubitecan in recurrent or metastatic head and neck cancer.
Cancer chemotherapy and pharmacology 2008;62(2):209-14.
2008: Droz Jean-Pierre; Rodde-Dunet Marie-Hélène; Vitoux Anne
[Development of oncogeriatry: national and international strategies]
Bulletin du cancer 2008;95 FMC Onco():F104-7.
2008: Fléchon Aude; Rivoire Michel; Droz Jean-Pierre
Management of advanced germ-cell tumors of the testis.
Nature clinical practice. Urology 2008;5(5):262-76.
2008: Boyle Helen; Droz Jean-Pierre
[Diagnosis of cancer. Signs, staging and prognosis]
La Revue du praticien 2008;58(8):899-908.
2008: Droz Jean-Pierre; Chaladaj Agnieska
Management of metastatic prostate cancer: the crucial role of geriatric assessment.
BJU international 2008;101 Suppl 2():23-9.
2008: Monfardini Silvio; Gridelli Cesare; Pasetto Lara M; Soubeyran Pierre; Droz Jean-Pierre; Basso Umberto
Vulnerable and frail elderly: an approach to the management of the main tumour types.
European journal of cancer (Oxford, England : 1990) 2008;44(4):488-93.
2008: Krege Susanne; Beyer Jörg; Souchon Rainer; Albers Peter; Albrecht Walter; Algaba Ferran; Bamberg Michael; Bodrogi István; Bokemeyer Carsten; Cavallin-Ståhl Eva; Classen Johannes; Clemm Christoph; Cohn-Cedermark Gabriella; Culine Stéphane; Daugaard Gedske; De Mulder Pieter H M; De Santis Maria; de Wit Maike; de Wit Ronald; Derigs Hans Günter; Dieckmann Klaus-Peter; Dieing Annette; Droz Jean-Pierre; Fenner Martin; Fizazi Karim; Flechon Aude; Fosså Sophie D; del Muro Xavier Garcia; Gauler Thomas; Geczi Lajos; Gerl Arthur; Germa-Lluch Jose Ramon; Gillessen Silke; Hartmann Jörg T; Hartmann Michael; Heidenreich Axel; Hoeltl Wolfgang; Horwich Alan; Huddart Robert; Jewett Michael; Joffe Johnathan; Jones William G; Kisbenedek László; Klepp Olbjørn; Kliesch Sabine; Koehrmann Kai Uwe; Kollmannsberger Christian; Kuczyk Markus; Laguna Pilar; Galvis Oscar Leiva; Loy Volker; Mason Malcolm D; Mead Graham M; Mueller Rolf; Nichols Craig; Nicolai Nicola; Oliver Tim; Ondrus Dalibor; Oosterhof Gosse O N; Ares Luis Paz; Pizzocaro Giorgio; Pont Jörg; Pottek Tobias; Powles Tom; Rick Oliver; Rosti Giovanni; Salvioni Roberto; Scheiderbauer Jutta; Schmelz Hans-Ulrich; Schmidberger Heinz; Schmoll Hans-Joachim; Schrader Mark; Sedlmayer Felix; Skakkebaek Niels E; Sohaib Aslam; Tjulandin Sergei; Warde Padraig; Weinknecht Stefan; Weissbach Lothar; Wittekind Christian; Winter Eva; Wood Lori; von der Maase Hans
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
European urology 2008;53(3):478-96.
2008: Krege Susanne; Beyer Jörg; Souchon Rainer; Albers Peter; Albrecht Walter; Algaba Ferran; Bamberg Michael; Bodrogi István; Bokemeyer Carsten; Cavallin-Ståhl Eva; Classen Johannes; Clemm Christoph; Cohn-Cedermark Gabriella; Culine Stéphane; Daugaard Gedske; De Mulder Pieter H M; De Santis Maria; de Wit Maike; de Wit Ronald; Derigs Hans Günter; Dieckmann Klaus-Peter; Dieing Annette; Droz Jean-Pierre; Fenner Martin; Fizazi Karim; Flechon Aude; Fosså Sophie D; del Muro Xavier Garcia; Gauler Thomas; Geczi Lajos; Gerl Arthur; Germa-Lluch Jose Ramon; Gillessen Silke; Hartmann Jörg T; Hartmann Michael; Heidenreich Axel; Hoeltl Wolfgang; Horwich Alan; Huddart Robert; Jewett Michael; Joffe Johnathan; Jones William G; Kisbenedek László; Klepp Olbjørn; Kliesch Sabine; Koehrmann Kai Uwe; Kollmannsberger Christian; Kuczyk Markus; Laguna Pilar; Galvis Oscar Leiva; Loy Volker; Mason Malcolm D; Mead Graham M; Mueller Rolf; Nichols Craig; Nicolai Nicola; Oliver Tim; Ondrus Dalibor; Oosterhof Gosse O N; Paz-Ares Luis; Pizzocaro Giorgio; Pont Jörg; Pottek Tobias; Powles Tom; Rick Oliver; Rosti Giovanni; Salvioni Roberto; Scheiderbauer Jutta; Schmelz Hans-Ulrich; Schmidberger Heinz; Schmoll Hans-Joachim; Schrader Mark; Sedlmayer Felix; Skakkebaek Niels E; Sohaib Aslam; Tjulandin Sergei; Warde Padraig; Weinknecht Stefan; Weissbach Lothar; Wittekind Christian; Winter Eva; Wood Lori; von der Maase Hans
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
European urology 2008;53(3):497-513.
2008: Culine Stéphane; Kramar Andrew; Théodore Christine; Geoffrois Lionel; Chevreau Christine; Biron Pierre; Nguyen Binh Bui; Héron Jean-François; Kerbrat Pierre; Caty Armelle; Delva Rémy; Fargeot Pierre; Fizazi Karim; Bouzy Jeannine; Droz Jean-Pierre;
Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):421-7.
2008: Bonnin Nathalie; El Karak Fadi; Droz Jean-Pierre; Flechon Aude
Pleural metastasis in a patient with bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):329-30.
2008: Ismaili Nabil; Naciri Sarah; Afqir Said; Mellas Nawfel; Bekkouch Imane; Elmajjaoui Sanaa; Masbah Ouafae; Othmani Nazih; Flechon Aude; Droz Jean Pierre; Errihani Hassan
A rare case of advanced testicular seminoma in a 78-year-old man managed successfully with carboplatin based chemotherapy: a case report.
Cases journal 2008;1(1):357.
2007: Culine S; Kerbrat P; Kramar A; Théodore C; Chevreau C; Geoffrois L; Bui N B; Pény J; Caty A; Delva R; Biron P; Fizazi K; Bouzy J; Droz J P;
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):917-24.
2007: Fléchon A; Droz J P
[Testis germ cell tumours: which chemotherapy, for which patients?]
Annales d'urologie 2007;41(2):56-67.
2007: Droz Jean-Pierre; Kramar Andrew; Biron Pierre; Pico José-Luis; Kerbrat Pierre; Pény Jean; Curé Hervé; Chevreau Christine; Théodore Christine; Bouzy Jeannine; Culine Stéphane;
Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
European urology 2007;51(3):739-46; discussion 747-8.
2007: de Bono Johann Sebastian; Bellmunt Joaquim; Attard Gerhardt; Droz Jean Pierre; Miller Kurt; Flechon Aude; Sternberg Cora; Parker Chris; Zugmaier Gerhard; Hersberger-Gimenez Veronica; Cockey Louise; Mason Malcolm; Graham John
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):257-62.
2006: Flechon Aude; Droz Jean-Pierre
Chemotherapy practices and perspectives in invasive bladder cancer.
Expert review of anticancer therapy 2006;6(10):1473-82.
2006: Devouassoux-Shisheboran Mojgan; Deschildre Catherine; Mauduit Claire; Berger Gérard; Mejean-Lebreton Frédérique; Bouvier Raymonde; Droz Jean Pierre; Fénichel Patrick; Benahmed Mohamed
Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
Oncology reports 2006;16(2):335-40.
2006: Pavic M; Meeus P; Treilleux I; Droz J P
Malignant teratoma 32 years after treatment of germ cell tumor confined to testis.
Urology 2006;67(4):846.e11-3.
2006: Andjilani Maoulana; Droz Jean-Pierre; Benahmed Mohamed; Tabone Eric
Down-regulation of FAK and IAPs by laminin during cisplatin-induced apoptosis in testicular germ cell tumors.
International journal of oncology 2006;28(2):535-42.
2006: Terret Catherine; Albrand Gilles; Jeanton Martine; Courpron Philippe; Droz Jean-Pierre
[What's new in geriatric oncology?]
Bulletin du cancer 2006;93(1):119-23.
2005: Fléchon A; Culine S; Théodore C; Droz J-P
Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
European urology 2005;48(6):957-63; discussion 963-4.
2005: Piketty A-C; Fléchon A; Laplanche A; Nouyrigat E; Droz J-P; Théodore C; Fizazi K
The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.
British journal of cancer 2005;93(8):909-14.
2005: Andjilani Maoulana; Droz Jean-Pierre; Benahmed Mohamed; Tabone Eric
Alpha6 integrin subunit mediates laminin enhancement of cisplatin-induced apoptosis in testicular tumor germ cells.
International journal of cancer. Journal international du cancer 2005;117(1):68-81.
2005: Pico J-L; Rosti G; Kramar A; Wandt H; Koza V; Salvioni R; Theodore C; Lelli G; Siegert W; Horwich A; Marangolo M; Linkesch W; Pizzocaro G; Schmoll H-J; Bouzy J; Droz J-P; Biron P;
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1152-9.
2005: van Kesteren Charlotte; Zandvliet Anthe S; Karlsson Mats O; Mathôt Ron A A; Punt Cornelis J A; Armand Jean-Pierre; Raymond Eric; Huitema Alwin D R; Dittrich Christian; Dumez Herlinde; Roché Henri H; Droz Jean-Pierre; Ravic Miroslav; Yule S Murray; Wanders Jantien; Beijnen Jos H; Fumoleau Pierre; Schellens Jan H M
Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.
Investigational new drugs 2005;23(3):225-34.
2005: Ravaud Alain; Cerny Thomas; Terret Catherine; Wanders Jantien; Bui Binh Nguyen; Hess Dagmar; Droz Jean-Pierre; Fumoleau Pierre; Twelves Chris
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study.
European journal of cancer (Oxford, England : 1990) 2005;41(5):702-7.
2005: Lotz J-P; Bui B; Gomez F; Théodore C; Caty A; Fizazi K; Gravis G; Delva R; Peny J; Viens P; Duclos B; De Revel T; Curé H; Gligorov J; Guillemaut S; Ségura C; Provent S; Droz J-P; Culine S; Biron P;
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(3):411-8.
2005: Fombonne Joanna; Devouassoux-Shisheboran Mojgan; Bouvier Raymonde; Droz Jean-Pierre; Benahmed Mohamed; Krantic Slavica
Analysis of p16INK4A gene promoter in male germ-cell tumors: identification of a new point mutation.
Cancer detection and prevention 2005;29(1):1-7.
2004: Terret Catherine; Zulian Gilbert; Droz Jean-Pierre
Statements on the interdependence between the oncologist and the geriatrician in geriatric oncology.
Critical reviews in oncology/hematology 2004;52(2):127-33.
2004: Fizazi Karim; Culine Stéphane; Kramar Andrew; Amato Robert J; Bouzy Jeannine; Chen Isan; Droz Jean-Pierre; Logothetis Christopher J
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3868-76.
2004: Rademaker-Lakhai Jeany M; Terret Catherine; Howell Stephen B; Baud Christiane M; De Boer Richard F; Pluim Dick; Beijnen Jos H; Schellens Jan H M; Droz Jean-Pierre
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3386-95.
2004: Terret Catherine; Albrand Gilles; Droz Jean Pierre
Geriatric assessment in elderly patients with prostate cancer.
Clinical prostate cancer 2004;2(4):236-40.
2003: Droz Jean-Pierre; Flechon Aude; Terret Catherine
[Metastatic prostate cancer]
La Revue du praticien 2003;53(20):2258-62.
2003: de la Fouchardière C; Flechon A; Droz J P
Coagulopathy in prostate cancer.
The Netherlands journal of medicine 2003;61(11):347-54.
2003: Extermann Martine; Albrand Gilles; Chen Hongbin; Zanetta Sylvie; Schonwetter Ronald; Zulian Gilbert B; Cantor Alan; Droz Jean-Pierre
Are older French patients as willing as older American patients to undertake chemotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3214-9.
2003: Fizazi Karim; Rolland Frédéric; Chevreau Christine; Droz Jean-Pierre; Mery-Mignard Dominique; Culine Stéphane; Escudier Bernard
A phase II study of irinotecan in patients with advanced renal cell carcinoma.
Cancer 2003;98(1):61-5.
2003: Cereceda Luis E; Flechon Aude; Droz Jean-Pierre
Management of vertebral metastases in prostate cancer: a retrospective analysis in 119 patients.
Clinical prostate cancer 2003;2(1):34-40.
2003: Terret C; Zanetta S; Roché H; Schellens J H M; Faber M N; Wanders J; Ravic M; Droz J P;
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG).
European journal of cancer (Oxford, England : 1990) 2003;39(8):1097-104.
2003: Flechon Aude; Droz Jean-Pierre
Management of clinical stage I nonseminomatous germ-cell testis tumors.
Expert review of anticancer therapy 2003;3(1):21-30.
2003: Devouassoux-Shisheboran Mojgan; Mauduit Claire; Tabone Eric; Droz Jean Pierre; Benahmed Mohamed
Growth regulatory factors and signalling proteins in testicular germ cell tumours.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):212-24; discussion 224.
2003: Bokemeyer Carsten; Hartmann Jorg T; Fossa Sophie D; Droz Jean-P; Schmol Hans-J; Horwich Alan; Gerl Arthur; Beyer Jorg; Pont Jorg; Kanz Lothar; Nichols Craig R; Einhorn Lawrence
Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):49-59; discussion 59-63.
2003: Terret Catherine; Gaujard Sylvain; Droz Jean-Pierre
[Current views in geriatric oncology]
Bulletin du cancer 2003;90(1):93-6.
2002: Bachelot T; Gomez F; Biron P; Ray-Coquard I; Soler-Michel P; Philip I; Guastalla J P; Rebattu P; Dumortier A; Droz J P; Blay J Y
A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.
British journal of cancer 2002;87(10):1079-85.
2002: Flechon Aude; Bompas Emmanuelle; Biron Pierre; Droz Jean-Pierre
Management of post-chemotherapy residual masses in advanced seminoma.
The Journal of urology 2002;168(5):1975-9.
2002: Bompas Emmanuelle; Fléchon Aude; Biron Pierre; Droz Jean-Pierre
[Management of advanced seminoma: retrospective study of 96 patients]
Bulletin du cancer 2002;89(10):877-85.
2002: Van Kesteren Ch; Mathôt R A A; Raymond E; Armand J P; Dittrich Ch; Dumez H; Roché H; Droz J P; Punt C; Ravic M; Wanders J; Beijnen J H; Fumoleau P; Schellens J H M;
Population pharmacokinetics of the novel anticancer agent E7070 during four phase I studies: model building and validation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):4065-73.
2002: Clippe Christine; Clippe Sébastien; Yzebe Delphine; Flechon Aude; Droz Jean-Pierre
[Bladder cancer chemotherapy practice study]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2002;12(4):609-14.
2002: Escudier B; Droz J P; Rolland F; Terrier-Lacombe M J; Gravis G; Beuzeboc P; Chauvet B; Chevreau C; Eymard J C; Lesimple T; Merrouche Y; Oudard S; Priou F; Guillemare C; Gourgou S; Culine S;
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.
The Journal of urology 2002;168(3):959-61.
2002: Hartmann J T; Nichols C R; Droz J-P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1017-28.
2002: Bokemeyer Carsten; Nichols Craig R; Droz Jean-P; Schmoll Hans-J; Horwich Alan; Gerl Arthur; Fossa Sophie D; Beyer Jörg; Pont Jörg; Kanz Lothar; Einhorn Lawrence; Hartmann Jörg T
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1864-73.
2002: Droz Jean-Pierre; Flechon Aude; Lombard-Bohas Catherine
[Chemotherapy of neuroendocrine tumors]
La Revue du praticien 2002;52(3):285-9.
2002: Droz J-P; Fléchon A; Terret C
Prostate cancer: management of advanced disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():89-94.
2001: Devouassoux-Shisheboran M; Mauduit C; Bouvier R; Berger F; Bouras M; Droz J P; Benahmed M
Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours.
Molecular human reproduction 2001;7(12):1099-105.
2001: Hartmann J T; Fossa S D; Nichols C R; Droz J P; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute 2001;93(22):1733-8.
2001: Fizazi K; Amato R J; Beuzeboc P; Petit N; Bouhour D; Thiss A; Rebischung C; Chevreau C; Logothetis C J; Droz J P
Germ cell tumors in patients infected by the human immunodeficiency virus.
Cancer 2001;92(6):1460-7.
2001: Lagrange J L; Ramaioli A; Theodore C H; Terrier-Lacombe M J; Beckendorf V; Biron P; Chevreau C H; Chinet-Charrot P; Dumont J; Delobel-Deroide A; D'Anjou J; Chassagne C; Parache R M; Karsenty J M; Mercier J; Droz J P;
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1313-9.
2001: Fléchon A; Rivoire M; Biron P; Droz J P
Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors.
The Journal of urology 2001;165(6 Pt 1):1920-6.
2001: Fizazi K; Tjulandin S; Salvioni R; Germà-Lluch J R; Bouzy J; Ragan D; Bokemeyer C; Gerl A; Fléchon A; de Bono J S; Stenning S; Horwich A; Pont J; Albers P; De Giorgi U; Bower M; Bulanov A; Pizzocaro G; Aparicio J; Nichols C R; Théodore C; Hartmann J T; Schmoll H J; Kaye S B; Culine S; Droz J P; Mahé C
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2647-57.
2001: Bokemeyer C; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Schmoll H J; Kanz L; Einhorn L; Nichols C R; Hartmann J T
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Cancer 2001;91(7):1394-401.
2001: Alexandre J; Fizazi K; Mahé C; Culine S; Droz J P; Théodore C; Terrier-Lacombe M J
Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse.
European journal of cancer (Oxford, England : 1990) 2001;37(5):576-82.
2001: Hartmann J T; Einhorn L; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Schmoll H J; Kanz L; Bokemeyer C
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1641-8.
2001: Fléchon A; Culine S; Droz J P
Intensive and timely chemotherapy, the key of success in testicular cancer.
Critical reviews in oncology/hematology 2001;37(1):35-46.
2001: Baou N; Bouras M; Droz J P; Dutrieux-Berger N; Bouvier R; Benahmed M; Krantic S
Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumors.
Cancer detection and prevention 2001;25(5):446-53.
2000: Andre F; Fizazi K; Culine S; Droz J P; Gatineau M; Takahashi Y; Oudard S; Theodore C
Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection.
American journal of clinical oncology 2000;23(5):460-2.
2000: André F; Fizazi K; Culine S; Droz J; Taupin P; Lhommé C; Terrier-Lacombe M; Théodore C
The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients.
European journal of cancer (Oxford, England : 1990) 2000;36(11):1389-94.
2000: Hartmann J T; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Einhorn L; Kanz L; Bokemeyer C
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Cancer 2000;88(11):2629-35.
2000: Baou N; Bouras M; Droz J P; Benahmed M; Krantic S
Evidence for a selective loss of somatostatin receptor subtype expression in male germ cell tumors of seminoma type.
Carcinogenesis 2000;21(4):805-10.
2000: Bachelot T; Ray-Coquard I; Catimel G; Ardiet C; Guastalla J P; Dumortier A; Chauvin F; Droz J P; Philip T; Clavel M
Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):151-6.
2000: Bouras M; Tabone E; Bertholon J; Sommer P; Bouvier R; Droz J P; Benahmed M
A novel SMAD4 gene mutation in seminoma germ cell tumors.
Cancer research 2000;60(4):922-8.
2000: Fléchon A; Droz J P
[Germ cell tumors of the testes: state of the art]
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2000;4(1):27-31.
2000: Hartmann J T; Nichols C R; Droz J P; Horwich A; Gerl A; Fossa S D; Beyer J; Pont J; Fizazi K; Einhorn L; Kanz L; Bokemeyer C
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.
Journal of the National Cancer Institute 2000;92(1):54-61.
1999: Fléchon A; Biron P; Droz J P
High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experience.
International journal of cancer. Journal international du cancer 1999;83(6):844-7.
1999: Fléchon A; Biron P; Philip I; Blay J Y; Droz J P
[High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]
Bulletin du cancer 1999;86(4):391-9.
1999: Culine S; Kramar A; Droz J P; Théodore C
Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer.
The Journal of urology 1999;161(1):173-5.
1999: Ardiet C J; Tranchand B; Zanetta S; Guillot A; Bernard E; Peguy M; Rebattu P; Droz J P
A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokinetics.
Investigational new drugs 1999;17(4):325-33.
1998: Culine S; Bekradda M; Kramar A; Rey A; Escudier B; Droz J P
Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.
Cancer 1998;83(12):2548-53.
1998: Culine S; Kattan J; Zanetta S; Théodore C; Fizazi K; Droz J P
Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer.
American journal of clinical oncology 1998;21(5):470-4.
1998: Kollmannsberger C; Beyer J; Droz J P; Harstrick A; Hartmann J T; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll H J; Kanz L; Bokemeyer C
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3386-91.
1998: Culine S; Abs L; Terrier-Lacombe M J; Théodore C; Wibault P; Droz J P
Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experience.
European journal of cancer (Oxford, England : 1990) 1998;34(3):353-8.
1998: Fizazi K; Culine S; Droz J P; Terrier-Lacombe M J; Théodore C; Wibault P; Rixe O; Ruffié P; Le Chevalier T
Initial management of primary mediastinal seminoma: radiotherapy or cisplatin-based chemotherapy?
European journal of cancer (Oxford, England : 1990) 1998;34(3):347-52.
1998: Fizazi K; Culine S; Droz J P; Kramar A; Théodore C; Ruffié P; Le Chevalier T
Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):725-32.
1998: Ray-Coquard I; Biron P; Bachelot T; Guastalla J P; Catimel G; Merrouche Y; Droz J P; Chauvin F; Blay J Y
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Cancer 1998;82(1):134-40.
1997: Culine S; Philippot I; Farhat F; Théodore C; Terrier-Lacombe M J; Droz J P
Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumors.
Bulletin du cancer 1997;84(4):368-72.
1997: Culine S; Théodore C; Bekradda M; Farhat F; Terrier-Lacombe M J; Droz J P
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors.
American journal of clinical oncology 1997;20(2):184-8.
1997: Fizazi K; Culine S; Droz J P; Le Chevalier T; Ruffié P; Théodore C
[Primary mediastinal non-seminomatous germ-cell tumors: from clinics to biology]
Bulletin du cancer 1997;84(3):313-27.
1997: Culine S; Theodore C; Terrier-Lacombe M J; Droz J P
Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
The Journal of urology 1997;157(3):855-8; discussion 858-9.
1997: Culine S; Theodore C; Court B H; Perrin J L; Droz J P
Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.
British journal of urology 1997;79(2):258-62.
1997: Culine S; Lhomme C; Kattan J; Michel G; Duvillard P; Droz J P
Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institut Gustave Roussy Experience.
Gynecologic oncology 1997;64(1):160-5.
1996: Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz J P
Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
Journal of surgical oncology 1996;62(1):40-5.
1996: Culine S; Theodore C; Terrier-Lacombe M J; Droz J P
Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.
The Journal of urology 1996;155(4):1296-8.
1996: Farhat F; Culine S; Lhommé C; Duvillard P; Soulié P; Michel G; Terrier-Lacombe M J; Théodore C; Schreinerova M; Droz J P
Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients.
Cancer 1996;77(7):1363-6.
1996: Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe M J; Droz J P
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
Journal of surgical oncology 1996;61(3):195-8.
1996: Farhat F; Culine S; Théodore C; Békradda M; Terrier-Lacombe M J; Droz J P
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
Cancer 1996;77(6):1193-7.
1995: Culine S; Lhomme C; Farhat F; Droz J P
Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1890-1.
1995: Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Gerbaulet A; Droz J P
Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy.
Gynecologic oncology 1995;58(3):344-8.
1995: Farhat F; Culine S; Lhomme C; Duvillard P; Terrier-Lacombe M J; Michel G; Soulie P; Theodore C; Lotz J P; Droz J P
[Desmoplastic small round cell tumors in adults: a new entity]
Bulletin du cancer 1995;82(8):665-73.
1995: Vénuat A M; Droz J P; Terrier-Lacombe M J; Machavoine C; Bernheim A
Cytogenetic study of a case of synchronous bilateral seminoma.
Cancer genetics and cytogenetics 1995;81(1):17-9.
1995: Mounedji-Boudiaf L; Rougier P; Culine S; de Baere T; Lasser P; Escudier B; Ducreux M; Kaloustian E; Droz J P; Roche A
[Treatment of metastatic malignant insulinomas. 2 cases]
Presse médicale (Paris, France : 1983) 1995;24(19):894-6.
1995: Farhat F; Culine S; Terrier-Lacombe M J; Droz J P
[Adenocarcinoma of rete testis. Apropos of a case and review of the literature]
Bulletin du cancer 1995;82(2):167-72.
1995: Ostronoff M; Soussain C; Zambon E; Moran A; Droz J P; Bosq J; Bayle C; Cosset J M; Hayat M
Localized stage non-Hodgkin's lymphoma of the testis: a retrospective study of 16 cases.
Nouvelle revue française d'hématologie 1995;37(5):267-72.
1995: Culine S; Bekradda M; Terrier-Lacombe M J; Droz J P
Treatment of sarcomatoid renal cell carcinoma: is there a role for chemotherapy?
European urology 1995;27(2):138-41.
1995: Kattan J; Culine S; Theodore C; Droz J P
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
Cancer investigation 1995;13(3):276-9.
1995: Pico J L; Fadel E; Ibrahim A; Bourhis J H; Droz J P
High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Bulletin du cancer 1995;82 Suppl 1():56s-60s.
1994: Kattan J; Spatz A; Culine S; Terrier-Lacombe M J; Elias D; Droz J P
Hepatocellular carcinoma during hormonotherapy for prostatic cancer.
American journal of clinical oncology 1994;17(5):390-2.
1994: Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz J P
[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors]
Bulletin du cancer 1994;81(10):871-6.
1994: Moran-Ribon A; Droz J P; Kattan J; Leclercq B; Ghosn M; Couanet D; Ostronoff M; Culine S; Misset B; Escudier B
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven cases.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(4):253-8.
1994: Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz J P
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary.
Gynecologic oncology 1994;54(1):47-53.
1994: Kattan J; Durand M; Droz J P; Mahjoubi M; Marino J P; Azab M
Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion schedule.
American journal of clinical oncology 1994;17(3):242-5.
1994: Mounedji-Boudiaf L; Culine S; Devoldère G; Terrier-Lacombe M J; Kattan J; Cazier A; Farhat F; Bekradda M; Droz J P
[Primary, highly malignant B-cell lymphoma of the prostate. Apropos of a case and review of the literature]
Bulletin du cancer 1994;81(4):334-7.
1994: Culine S; Terrier-Lacombe M J; Kattan J; Droz J P
[Carcinoma in situ of the testis]
Bulletin du cancer 1994;81(4):318-25.
1994: Chraibi Y; Culine S; Terrier-Lacombe M J; Kramar A; Kattan J; Droz J P
[Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases]
Bulletin du cancer 1994;81(4):311-7.
1994: Farhat F; Kattan J; Culine S; Théodore C; Terrier-Lacombe M J; Génin J; Mounedji-Boudiaf L; Bekradda M; Droz J P
[Liposarcoma of the spermatic cord: apropos of a case with review of the literature]
Bulletin du cancer 1994;81(3):223-5.
1994: Kattan J; Culine S; Tavakoli-Razavi T; Kramar A; Droz J P
Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1994;2(2):128-31.
1994: Kattan J; Droz J P; Culine S; Escudier B; Beaumont-Raymond C
Recombinant interferon-alpha efficacy in relapsed adult nephroblastoma: a case report.
The Journal of urology 1994;151(2):411-2.
1994: Farhat F; Kattan J; Culine S; Bekradda M; Droz J P
[Efficacy of the combination of 5 fluorouracil, adriamycin and cisplatin (FAP protocol) in the treatment of metastatic cylindroma. Apropos of a case with review of the literature]
Bulletin du cancer 1994;81(1):47-50.
1994: Kattan J; Tournade M F; Culine S; Terrier-Lacombe M J; Droz J P
Adult Wilms' tumour: review of 22 cases.
European journal of cancer (Oxford, England : 1990) 1994;30A(12):1778-82.
1994: Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Droz J P
Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
European journal of cancer (Oxford, England : 1990) 1994;30A(9):1239-44.
1994: Droz J P; De Smedt E; Kattan J; Keuppens F; Khoury S; Mahler C; Denis L
Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate.
The Prostate 1994;24(2):62-6.
1993: Kattan J; Culine S; Terrier-Lacombe M J; Théodore C; Droz J P
Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):871-5.
1993: Pico J L; Ibrahim A; Castagna L; Bourhis J H; Chazard M; Maraninchi D; Droz J P
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors.
Oncology 1993;50 Suppl 2():47-52.
1993: Mahjoubi M; Kattan J; Bonnay M; Schmitt H; Droz J P
Phase II trial of LY 186641 in advanced renal cancer.
Investigational new drugs 1993;11(4):323-8.
1993: Kattan J; Culine S; Droz J P; Fadel E; Court B; Perrin J L; Wibault P; Haie-Meder C
Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy.
Urology 1993;42(5):559-62.
1993: Giacchetti S; Raoul Y; Wibault P; Droz J P; Court B; Eschwege F
Treatment of stage I testis seminoma by radiotherapy: long-term results--a 30-year experience.
International journal of radiation oncology, biology, physics 1993;27(1):3-9.
1993: Kattan J; Droz J P; Culine S; Duvillard P; Thiellet A; Peillon C
The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary.
Gynecologic oncology 1993;49(3):395-9.
1993: Marcillac I; Cottu P; Théodore C; Terrier-Lacombe M J; Bellet D; Droz J P
Free hCG-beta subunit as tumour marker in urothelial cancer.
Lancet 1993;341(8856):1354-5.
1993: Rougier P; Zarba J J; Ducreux M; Basile M; Pignon J P; Mahjoubi M; Benahmed M; Droz J P; Cvitkovic E; Armand J P
Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(4):333-6.
1993: Douchez J; Droz J P; Desclaux B; Allain Y; Fargeot P; Caty A; Charrot P
Quality of life in long-term survivors of nonseminomatous germ cell testicular tumors.
The Journal of urology 1993;149(3):498-501.
1993: Kattan J; Droz J P; Culine S
[High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma]
Bulletin du cancer 1993;80(3):248-54.
1993: Droz J P; Kattan J; Bonnay M; Chraibi Y; Bekradda M; Culine S
High-dose continuous-infusion fosfestrol in hormone-resistant prostate cancer.
Cancer 1993;71(3 Suppl):1123-30.
1993: Droz J P; Pico J L; Kramar A
Role of autologous bone marrow transplantation in germ-cell cancer.
The Urologic clinics of North America 1993;20(1):161-71.
1993: Droz J P; Théodore C
[Use of G-CSF in chemotherapy of urogenital cancers]
Pathologie-biologie 1993;41(1):48-9.
1993: Mahjoubi M; Kattan J; Droz J P; Philippot I; Pautier P; Boutan-Laroze A; Azab M; Theodore C
Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(2):285-6.
1993: Droz J P; van Oosterom A T
Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review.
European journal of cancer (Oxford, England : 1990) 1993;29A(7):1038-44.
1993: Droz J P; Kramar A; Pico J L
Prediction of long-term response after high-dose chemotherapy with autologous bone marrow transplantation in the salvage treatment of non-seminomatous germ cell tumours.
European journal of cancer (Oxford, England : 1990) 1993;29A(6):818-21.
1993: Kramar A; Droz J P; Rey A; Bouzy J; Philippot I; Culine S
Prognostic factors in non-seminomatous germ cell tumours of the testis. Experience at the Institut Gustave-Roussy.
European urology 1993;23(1):188-95.
1993: Kattan J; Mahjoubi M; Droz J P; Kramar A; Culine S; Boutan-Laroze A; Chazard M
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.
European journal of cancer (Oxford, England : 1990) 1993;29A(11):1504-9.
1992: Mahjoubi M; Kattan J; Ghosn M; Droz J P; Philippot I; Herait P
Phase II trial of pirarubicin in the treatment of advanced bladder cancer.
Investigational new drugs 1992;10(4):317-21.
1992: Bidart J M; Troalen F; Lazar V; Berger P; Marcillac I; Lhomme C; Droz J P; Bellet D
Monoclonal antibodies to the free beta-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules.
Endocrinology 1992;131(4):1832-40.
1992: Kattan J; Droz J P; Couvreur P; Marino J P; Boutan-Laroze A; Rougier P; Brault P; Vranckx H; Grognet J M; Morge X
Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.
Investigational new drugs 1992;10(3):191-9.
1992: Kattan J; Droz J P; Charpentier P; Michel G; Lhommé C; Boutan-Laroze A; Prade M
Ovarian dysgerminoma metastatic to the breast.
Gynecologic oncology 1992;46(1):104-6.
1992: Marcillac I; Troalen F; Bidart J M; Ghillani P; Ribrag V; Escudier B; Malassagne B; Droz J P; Lhommé C; Rougier P
Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms.
Cancer research 1992;52(14):3901-7.
1992: Droz J P; Kramar A; Wibault P; Perrin J J; Roche A; Escudier B; Missenard G; Court B H
[Therapeutic strategy in metastatic renal cancer]
La Revue du praticien 1992;42(10):1253-7.
1992: Droz J P; Kramar A; Rey A
Prognostic factors in metastatic disease.
Seminars in oncology 1992;19(2):181-9.
1992: Droz J P; Lhommé C
[Gestational trophoblastic tumors]
La Revue du praticien 1992;42(7):817-22.
1992: Droz J P; Ruffié P
[Germinal tumors of the mediastinum. Therapeutic strategy, prognosis, biology]
Revue des maladies respiratoires 1992;9(3):251-4.
1992: Ruffié P; Droz J P
[Mediastinal seminoma. Is it an entity to be treated differently?]
Revue des maladies respiratoires 1992;9(3):245-9.
1992: Kattan J; Droz J P; Ribrag V; Azab M; Boutan-Laroze A; Andremont A
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):867-70.
1992: Kattan J; Droz J P; Culine S; Ribrag V; Boutan-Laroze A; Andremont A
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy]
Bulletin du cancer 1992;79(7):705-12.
1992: Droz J P; Pico J L; Ghosn M; Kramar A; Rey A; Ostronoff M; Baume D
A phase II trial of early intensive chemotherapy with autologous bone marrow transplantation in the treatment of poor prognosis non seminomatous germ cell tumors.
Bulletin du cancer 1992;79(5):497-507.
1992: Droz J P
[Report of the ASCO and AACR II congress, San Diego, 17-23 May 1992. Plenary session and urologic oncology sessions]
Bulletin du cancer 1992;79(9):909-15.
1992: Droz J P; Cosset J M
[Go France ... ASCO/AACR congress, San Diego I, 17-23 May 1992]
Bulletin du cancer 1992;79(9):829-35.
1992: Ribrag V; Droz J P; Kattan J; Andremont A
Infectious complications associated with granulocytopenia during the treatment of poor risk or relapsed germ cell tumors.
Bulletin du cancer 1992;79(5):491-5.
1992: Ostronoff M; Soussain C; Zambon E; Ibrahim A; Bosq J; Bayle C; Pico J L; Gilles E; Moran A; Droz J P
Burkitt's lymphoma in adults: a retrospective study of 46 cases.
Nouvelle revue française d'hématologie 1992;34(5):389-97.
1992: Soussain C; Michel-Langlet P; Mahjoubi M; Terrier-Lacombe M J; Droz J P
[Brain metastasis of choriocarcinoma in males. Apropos of a case. Review of the literature]
Bulletin du cancer 1992;79(8):751-7.
1991: Schlumberger M; Brugieres L; Gicquel C; Travagli J P; Droz J P; Parmentier C
5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.
Cancer 1991;67(12):2997-3000.
1991: Kattan J; Droz J P; Boutan-Laroze A; Deforges B; Terrier-Lacombe M J; Vanel D; Lusinchi A
[Choroid metastasis in a case of urothelial carcinoma metastatic from the bladder]
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 1991;1(3):466-9.
1991: Schlumberger M; Parmentier C; Delisle M J; Couette J E; Droz J P; Sarrazin D
Combination therapy for anaplastic giant cell thyroid carcinoma.
Cancer 1991;67(3):564-6.
1991: Boutan-Laroze A; Mahjoubi M; Droz J P; Charrot P; Fargeot P; Kerbrat P; Caty A; Voisin P M; Spielmann M; Rey A
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.
European journal of cancer (Oxford, England : 1990) 1991;27(12):1690-4.
1991: Culine S; Mahjoubi M; Philippot I; Droz J P
Treatment of good-risk disseminated non-seminomatous germ cell tumours: the less bleomycin, the more cisplatin?
European journal of cancer (Oxford, England : 1990) 1991;27(12):1715.
1991: Droz J P; Pico J L; Ghosn M; Gouyette A; Baume D; Piot G; Ostronoff M; Theodore C; Beaujean F; Hayat M
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(7):831-5.
1991: Rougier P; Oliveira J; Ducreux M; Theodore C; Kac J; Droz J P
Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1380-2.
1990: Ribrag V; Droz J P; Bouleuc C; Theodore C; Ghosn M; Pico J L; Azab M; Ostronoff M; Hayat M
[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin]
Presse médicale (Paris, France : 1983) 1990;19(27):1263-6.
1990: Terrier-Lacombe M J; Martinez-Madrigal F; Porta W; Rahal J; Droz J P
Embryonal rhabdomyosarcoma arising in a mature teratoma of the testis: a case report.
The Journal of urology 1990;143(6):1232-4.
1990: Droz J P; Pico J L; Ghosn M; Ostronoff M; Azab M; Theodore C; Hayat M
[Chemotherapeutic intensification in germ cell tumors]
Bulletin du cancer 1990;77(4):349-54.
1990: Hayat M; Ostronoff M; Gilles E; Zambon E; Baume D; Moran A; Carde P; Droz J P; Pico J L
Salvage therapy with methyl-gag, high-dose Ara-C, M-Amsa, and ifosfamide (MAMI) for recurrent or refractory lymphoma.
Cancer investigation 1990;8(1):1-5.
1990: Eschwege F; Rougier P; Delanian S; Abensour L; Droz J P; Wibault P; Lusinchi A; Lasser P
[Combination radiotherapy and chemotherapy in the treatment of locally advanced adenocarcinoma of the pancreas. Experiences of the Gustave Roussy Institute]
Bulletin du cancer 1990;77(3):245-9.
1990: Guimaraes J L; Ghosn M; Ostronoff M; Azab M; Theodore C; Droz J P
Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.
Cancer investigation 1990;8(6):623-4.
1990: Ribrag V; Ghnassia M; Théodore C; Ghosn M; Piot G; Beurton D; Cukier J; Droz J P
[Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin]
Journal d'urologie 1990;96(7):373-4.
1990: Droz J P; Azab M B; Theodore C; Ghosn M; Ostronoff M; Boutan-Laroze A; Court B H; Perrin J L; Travagli J P; Wibault P
Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experience.
Progress in clinical and biological research 1990;353():137-42.
1990: Ghosn M; Ha M C; Pietri F; Garcin C; Théodore C; Droz J P
[Trial of premedication with lorazepam for the prevention of emetic effects of cisplatin]
Bulletin du cancer 1990;77(7):695-6.
1990: Lupera H; Droz J P; Culine S; Perrin J L; Court B H; Ghosn M; Hayat M
[Cancer of the bladder after treatment with cyclophosphamide. Apropos of a case and a review of the literature]
Journal d'urologie 1990;96(1):48-52.
1990: Droz J P; Ruffie P; Piot G; Ghosn M; Caillaud J M; Elias D; Perrin J L; Levasseur P
Sarcoidosis and testicular germ cell tumor. Case report.
Scandinavian journal of urology and nephrology 1990;24(3):171-3.
1990: Baume D; Pico J L; Droz J P; Ostronoff M; Azab M; Gilles E; Ghosn M; Salloum E; Gouyette A; Beaujean F
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]
Bulletin du cancer 1990;77(2):169-80.
1990: Mahjoubi M; Azab M; Ghosn M; Theodore C; Droz J P
Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.
Cancer investigation 1990;8(5):477-81.
1989: Lupera H; Theodore C; Ghosn M; Court B H; Wibault P; Droz J P
Phase II trial of combination chemotherapy with dacarbazine, cyclophosphamide, cisplatin, doxorubicin, and vindesine (DECAV) in advanced renal cell cancer.
Urology 1989;34(5):281-3.
1989: Theodore C; Azab M; Droz J P; Assouline A; George M; Piot G; Bellet D; Michel G; Amiel J L
Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
Cancer 1989;64(9):1824-8.
1989: Azab M; Droz J P; Theodore C; Wolff J P; Amiel J L
Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors.
Cancer 1989;64(9):1829-32.
1989: Azab M B; Henry-Amar M; Rougier P; Bognel C; Theodore C; Carde P; Lasser P; Cosset J M; Caillou B; Droz J P
Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature.
Cancer 1989;64(6):1208-17.
1989: Hayat M; Droz J P
[Medical treatment of advanced cancers of the breast (metastatic and at metastatic high-risk)]
Bulletin du cancer 1989;76(1):63-4.
1989: Rougier P; Oliveira J; Ducreux M; Theodore C; Azab M; Droz J P
[Efficacy of chemotherapy and combined chemo-radiotherapy in gastric adenocarcinoma]
Bulletin du cancer 1989;76(9):1007-20.
1989: Eschwege F; Raoul Y; Wibault P; Droz J P; Court B; Perrin J L
Does radiotherapy still have a place in the treatment of bladder tumors?
Progress in clinical and biological research 1989;303():605-11.
1989: Culine S; Azab M; Pietri F; Ghosn M; Ben Amor B; Lupera H; Theodore C; Renaux J; Droz J P
[A phase III trial comparing the antiemetic activity of tetracosactide with dexamethasone in combination with metoclopramide, diphenhydramine and clorazepate during chemotherapy including cisplatin]
Bulletin du cancer 1989;76(6):583-9.
1989: Louvet C; Guimaraes J L; Ostronoff M; Theodore C; Azab M; Leclercq B; Droz J P
[Paraneoplastic hypercalcemia and ovarian seminoma. Review of the literature and etiological discussion apropos of a case]
Bulletin du cancer 1989;76(4):347-52.
1989: Azab M; Theodore C; Cukier J; Beurton D; Gilles E; Droz J P
[Adjuvant chemotherapy using adriamycin and cisplatin in infiltrating cancer of the bladder. Prospective study of 49 cases]
Journal d'urologie 1989;95(8):459-63.
1989: Lupera H; Droz J P; Piot G; Lapleige P; Fargeot P; Theodore C
Phase II trial of combination chemotherapy with fluorouracil (F), doxorubicin (A), and cisplatin (P) (Fap) in hormonally resistant metastatic prostatic adenocarcinoma.
Oncology 1989;46(6):372-4.
1989: Droz J P; Ribrag V; Ghosn M; Guimares J; Theodore C; Azab M; Ostronoff M; Mahjoubi M; Moran A; Pico J
Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
Progress in clinical and biological research 1989;303():739-47.
1989: Rougier P; Lasser P; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S; Droz J P
Intra-arterial hepatic chemotherapy for metastatic liver from colo-rectal carcinoma origin.
Selective cancer therapeutics 1989;5(1):47-54.
1989: Raoul Y; Wibault P; Giacchetti S; Court B; Perrin B; Travagli J P; Droz J P; Eschwege F
[Invasive tumors of the bladder. A study of 56 cases treated at the Gustave-Roussy Institute by total cystectomy and radiotherapy]
Annales d'urologie 1989;23(3):205-11.
1989: Herait P; Rougier P; Theodore C; Kac J L; Droz J P
Alternating 5-FU-mitomycin C/5-FU-dacarbazine in advanced colorectal adenocarcinoma: a phase II study.
Oncology 1989;46(2):88-90.
1988: Azab M B; Pejovic M H; Theodore C; George M; Droz J P; Bellet D; Michel G; Amiel J L
Prognostic factors in gestational trophoblastic tumors. A multivariate analysis.
Cancer 1988;62(3):585-92.
1988: Droz J P; Kramar A; Ghosn M; Piot G; Rey A; Theodore C; Wibault P; Court B H; Perrin J L; Travagli J P
Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis.
Cancer 1988;62(3):564-8.
1988: Ghosn M; Droz J P; Theodore C; Pico J L; Baume D; Spielmann M; Ostronoff M; Moran A; Salloum E; Kramar A
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen.
Cancer 1988;62(1):24-7.
1988: Pastran Z; le Chevalier T; Baldeyrou P; Spielmann M; Arriagada R; Droz J P; Rouesse J
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma.
European journal of cancer & clinical oncology 1988;24(6):1073-4.
1988: Schlumberger M; Ostronoff M; Bellaiche M; Rougier P; Droz J P; Parmentier C
5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma.
Cancer 1988;61(8):1492-4.
1988: Piot G; Droz J P; Theodore C; Ghosn M; Rouëssé J; Amiel J L
Phase II trial with high-dose elliptinium acetate in metastatic renal cell carcinoma.
Oncology 1988;45(5):371-2.
1988: Droz J P; Theodore C; Ghosn M; Lupera H; Piot G; De Forges A; Klink M; Rouesse J; Amiel J L
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
Seminars in surgical oncology 1988;4(2):97-9.
1988: de Forges A; Rey A; Klink M; Ghosn M; Kramar A; Droz J P
Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis.
Seminars in surgical oncology 1988;4(3):149-54.
1988: Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz J P; Hayat M
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Bulletin du cancer 1988;75(4):391-2.
1988: Rougier P; Ychou M; Droz J P
[Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)]
Bulletin du cancer 1988;75(10):979-81.
1987: Rougier P; Droz J P; Theodore C; Piot G; Herait P; Ruffie P; Carde P; Cvitkovic E
Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma.
Cancer treatment reports 1987;71(12):1301-2.
1987: De Forges A; Droz J P; Ghosn M; Theodore C
Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
Cancer treatment reports 1987;71(11):1103.
1987: Rougier P; Lasser P; Droz J P; Elias D; Ghosn M; Ducreux M; Lumbroso J; Sidibe S
[Locoregional chemotherapy of hepatic metastases of colorectal cancer]
Annales de gastroentérologie et d'hépatologie 1987;23(6):315-9.
1987: Gouyette A; Deniel A; Pico J L; Droz J P; Baume D; Ostronoff M; le Bail N; Hayat M
Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies.
European journal of cancer & clinical oncology 1987;23(11):1627-32.
1987: Droz J P; Fargeot P; Laplaige P; Moran-Ribon A; Piot G
Phase II trial of the association of doxorubicin, 5 FU and cis platinum in hormonally unresponsive metastatic carcinoma of the prostate.
Progress in clinical and biological research 1987;243B():235-42.
1986: Lasser P; Elias D; Rougier P; Piot G; Droz J P; Lumbroso J; Amiel J L
[Isolated hepatic metastases. Treatment by intra-arterial chemotherapy using a subcutaneous access chamber]
Presse médicale (Paris, France : 1983) 1986;15(6):237-40.
1985: Piot G; Droz J P; Rougier P; Théodore C; Spielmann M; Carde P; Amiel J L
[Treatment of hepatic metastases with unknown primary cancer]
Annales de gastroentérologie et d'hépatologie 1985;21(2):91-3.
1985: Rougier P; Piot G; Lasser P; Elias D; Droz J P; Lumbroso J; Amiel J L
[Locoregional chemotherapy of hepatic metastases]
Chirurgie; mémoires de l'Académie de chirurgie 1985;111(7):548-51.
1985: Droz J P; Piot G; Théodore C; Amiel J L
[Chemosensitive metastatic cancer cured by surgery of the residual lesions]
Chirurgie; mémoires de l'Académie de chirurgie 1985;111(7):523-7.
1984: Amiel J L; Droz J P; Ben Ayed F
[Choriogonadotrophic hormone and placental tumors]
Annales d'endocrinologie 1984;45(4-5):231-3.
1983: Piot G; Droz J P; Caillaud J M; Bellet D; Wibault P; Brulé G; Amiel J L
[Relapses of malignant nonseminomatous germinal testicular tumors]
Journal d'urologie 1983;89(1):49-51.
1982: Gouyette A; Huertas D; Droz J P; Rouesse J; Amiel J L
Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study).
European journal of cancer & clinical oncology 1982;18(12):1285-92.
1982: Ben Ayed F; Bellet D; Badri N; Spielmann M; Droz J P; Tursz T; Amiel J L
[Factors of severity in placental choriocarcinoma]
Journal de gynécologie, obstétrique et biologie de la reproduction 1982;11(4):487-9.
1982: Brin M; Droz J P; Caillaud J M; Bellet D; Amiel J L; Brulé G
[Cerebral metastases of malignant germinal tumors of the testis]
Journal d'urologie 1982;88(6):345-7.
1982: Ben Ayed F; Bellet D; Badri N; Spielmann M; Droz J P; Tursz T; Amiel J L
[Recurrences of placental choriocarcinoma]
Journal de gynécologie, obstétrique et biologie de la reproduction 1982;11(3):383-4.
1982: Richer O; Droz J P; Lemoine G; Levasseur P; Amiel J L; Brulé G
[Role of the excision of thoracic lesions in the treatment of metastatic malignant germinal tumors of the testis]
Journal d'urologie 1982;88(6):349-51.
1982: Tursz T; Ben Ayed F; Droz J P; Spielmann M; Amiel J L
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)]
Bulletin du cancer 1982;69(1):28-32.
1981: Rouesse J; Tursz T; Le Chevalier T; Huertas D; Amiel J L; Brule G; Callet B; Droz J P; Voisin P M; Sancho-Garnier H; Le Pecq J B; Paoletti C
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]
La Nouvelle presse médicale 1981;10(24):1997-9.
1981: Ben Ayed F; Droz J P; Caillaud J M; Amiel J L
[Adult primary germ cell tumours outside the testes (author's transl)]
La Nouvelle presse médicale 1981;10(17):1389-91.
1980: Amiel J L; Michel G; Droz J P; Tursz T; Ben Ayed F
[Second laparotomy in cancers of the ovary treated with chemotherapy. 17 cases (author's transl)]
La Nouvelle presse médicale 1980;9(47):3605-8.
1980: Ben Ayed F; Droz J P; Caillaud J M; Amiel J L
[Germinal tumours of the mediastinum in adults, without testicular lesion (author's transl)]
Annales de chirurgie 1980;34(8):623-5.
1980: Amiel J L; Droz J P; Tursz T; Ben Ayed F; Gastiaburu J; Rouesse J
[Cis-diamminated-dichloroplatinum (CDDP) in the chemotherapy of testicular dysembryomas and choriocarcinomas (author's transl)]
Journal d'urologie 1980;86(6):463-5.
1980: Droz J P; Ben Ayed F; Pascal B; Beurton D; Cukier J; Amiel J L
[Therapeutic trials in inoperable carcinoma of the bladder (author's transl)]
Journal d'urologie 1980;86(6):479-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jean Pierre Droz

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jean Pierre Droz (preview)

All Publications